Ovid therapeutics Inc

14 сент. 2026 г., 20:08 UTC

Ovid Therapeutics Inc is higher as it advances mid-stage development of OV329 and initiates multiple clinical studies. Topline data for OV329 is expected by late 2026.

11 сент. 2026 г., 19:26 UTC

H.C. Wainwright raised Ovid Therapeutics' price target to $5.00, maintaining a Buy rating, contributing to positive sentiment as shares trade higher since Thursday's close.

9 сент. 2026 г., 19:46 UTC

Ovid Therapeutics Inc shares are lower amid rising crude oil prices above $100, raising inflation concerns that may affect monetary policy.

8 сент. 2026 г., 23:52 UTC

Ovid Therapeutics Inc is higher in after-market trading, reflecting positive momentum since Tuesday's close and positioning above its 20-day moving average.

1 сент. 2026 г., 20:09 UTC

Ovid Therapeutics Inc is higher today, recovering from an early dip amid broader market dynamics and rising oil prices fueling inflation concerns.

31 авг. 2026 г., 23:01 UTC

Ovid Therapeutics Inc shares are higher in after-market trading, moving from a low of 0.19% to a high of 4.69%.

28 авг. 2026 г., 20:07 UTC

Ovid Therapeutics Inc shares are lower today amid rising U.S. Treasury yields and broader market declines. The stock saw notable volatility earlier in the session.

24 авг. 2026 г., 19:16 UTC

Ovid Therapeutics Inc shares are higher today, recovering from an earlier dip. The stock remains above its 20-day moving average and last month's price.

21 авг. 2026 г., 19:46 UTC

Ovid Therapeutics Inc is trading higher, maintaining a position near its one-month range. Shares pulled back earlier in the session but are advancing overall.

20 авг. 2026 г., 23:31 UTC

Ovid Therapeutics Inc shares are higher in after-market trading, reflecting a significant shift in momentum since Thursday's close. No specific news was identified.

19 авг. 2026 г., 21:21 UTC

Ovid Therapeutics shares declined in after-market trading, finishing near the day's low after peaking earlier in the session. The stock remains above its 20-day moving average.

14 авг. 2026 г., 19:53 UTC

Ovid Therapeutics Inc shares are higher as the company advances its clinical pipeline, with key data releases planned through 2026, attracting positive market sentiment.

13 авг. 2026 г., 19:16 UTC

Ovid Therapeutics reported Q2 EPS of -$0.08, surpassing estimates. Shares are trading higher as the company advances its clinical pipeline and maintains $169.8 million in cash.

12 авг. 2026 г., 19:46 UTC

Ovid Therapeutics Inc shares are higher, supported by positive sentiment from a recent inflation report, despite earlier declines in the session.

7 авг. 2026 г., 19:26 UTC

Ovid Therapeutics Inc shares are lower today amid broader market dynamics. The stock briefly peaked earlier in the session before declining.

6 авг. 2026 г., 22:51 UTC

Ovid Therapeutics Inc. shares are lower in after-market trading, declining since Thursday's close despite remaining above its 20-day moving average.

5 авг. 2026 г., 21:03 UTC

Ovid Therapeutics Inc shares are higher in after-market hours, continuing a positive trend from four consecutive days of gains. No specific news was identified.

4 авг. 2026 г., 23:01 UTC

Ovid Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline since Tuesday's close.

3 авг. 2026 г., 19:11 UTC

Ovid Therapeutics shares are higher as Oppenheimer raises the price target to $9.00 from $7.00, maintaining an Outperform rating.

31 июл. 2026 г., 20:02 UTC

Ovid Therapeutics Inc shares are lower today amid rising Treasury yields and crude oil prices, contributing to broader inflation concerns affecting the biotechnology sector.

27 июл. 2026 г., 20:07 UTC

Ovid Therapeutics Inc shares are higher during Monday's session, following a cumulative gain since Friday. The stock pulled back from earlier session highs.

22 июл. 2026 г., 18:46 UTC

Ovid Therapeutics Inc shares are lower amid broader market volatility linked to rising crude oil prices and geopolitical tensions, with no specific news identified.

20 июл. 2026 г., 19:36 UTC

Ovid Therapeutics Inc shares are lower today, continuing a trend of declines amid broader market pressure from geopolitical tensions and rising oil prices.